Ray Kurzweil Joins Subsense to Develop AI-Driven Nasal Nanoparticle Brain Interface

What happened

AI pioneer Ray Kurzweil has joined Subsense, a Silicon Valley startup developing a non-surgical brain-computer interface that uses inhaled nanoparticles and AI to read and stimulate neural activity. The technology, still in preclinical stages, raises future safety and reliability concerns but has not yet caused harm.

Reported impact

Affected parties

Not publicly disclosed

Harm type

Not publicly disclosed

Scale

Not publicly disclosed

Financial impact

Not publicly disclosed

Regulatory action

Not publicly disclosed

Classification

Organization

Not publicly disclosed

AI system

Not publicly disclosed

Industry

Not publicly disclosed

Country

Not publicly disclosed

Provider

Not publicly disclosed

Incident type

Not publicly disclosed

Relevant governance controls

Governance control mapping is not available for this record.

• No controls mappedNot publicly disclosed

Control mapping is analytical. It does not state that any control would have prevented the incident.

Sources and evidence